Top Markets
#1 ADO Protocol ADO Protocol +328.85%
#2 Tutorial Tutorial +56.73%
#3 GoPlus Security GoPlus Security +51.87%
#4 Nockchain Nockchain +49.89%
#5 The Black Bull The Black Bull +36.28%
#6 Starpower Starpower +34.09%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +30.24%
#8 GAIB AID GAIB AID +24.67%
#9 Casper Network Casper Network +17.01%
#10 Verus Coin Verus Coin +16.19%
Coin of the day
ADO Protocol ADO Protocol
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Citius Pharmaceuticals, Inc. Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals, Inc.

CTXR
Pozycja w akcjach #33962
Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm... Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed towards anti-infective treatments supporting cancer care, various prescription medications, and pioneering mesenchymal stem cell therapies. The company is actively advancing five unique products within its pipeline: Mino-Lok: An antibiotic lock solution designed to combat catheter-related bloodstream infections by salvaging the infected central venous catheter. Mino-Wrap: A novel liquifying gel-based wrap aimed at minimizing infections associated with tissue expanders following breast reconstructive procedures. Halo-Lido: A topical formulation that blends a corticosteroid with lidocaine, intended to deliver both anti-inflammatory and numbing relief to individuals suffering from hemorrhoids. NoveCite: A mesenchymal stem cell therapy currently under development for treating acute respiratory distress syndrome (ARDS). I/ONTAK: An engineered fusion protein, combining IL-2 and diphtheria toxin, purposed for the treatment of patients experiencing persistent or recurrent cutaneous T-cell lymphoma. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Cena akcji
$0.5813
Kapitalizacja rynkowa
$6.50M
Zmiana (1 dzień)
-23.07%
Zmiana (1 rok)
-56.29%
Kraj
US
Handel Citius Pharmaceuticals, Inc. (CTXR)

Kategoria

Healthcare
Historia dywidend dla Citius Pharmaceuticals, Inc. (CTXR)
Citius Pharmaceuticals, Inc. (symbol giełdowy: CTXR) wypłaciła łącznie 0 dywidend.
Suma wszystkich dywidend (skorygowana o podziały akcji): 0.00
Wskaźnik dywidendy (TTM): 0
Wypłaty dywidend dla Citius Pharmaceuticals, Inc. (CTXR) od 2026 do 2026
Roczne wypłaty dywidend
Rok Dywidenda (skorygowana o podziały akcji) Zmień
Za mało danych dla podanych dat.
Lista wszystkich wypłat dywidend
Rok Dywidenda Zmień
Za mało danych dla podanych dat.
Wypłaty dywidend firm podobnych lub konkurencyjnych
Firma Liczba wypłat dywidend Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
29.00%
BE